Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Sanofi (Sanofi)
- License Information
-
More Information
Article History
Received: 21 April 2025
Accepted: 13 August 2025
First Online: 21 August 2025
Declarations
:
: This research was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and are consistent with Good Clinical Practice and applicable regulatory requirements. The adult study protocol was approved by Quorum Review (an independent ethics review board, now Advarra (please note, the Quorum Review archive is no longer available), and the adolescent study protocol was approved by the WCG IRB (study number 20233718). Informed consent was obtained from all participants and parents/caregivers of adolescent patients included in this research and they were remunerated for their time according to the Fair Market Value rates.
: All authors consent to publish the manuscript.
: JH and AH are employees of Sanofi and hold stocks and/or stock options in the company. JL was an employee of Sanofi when the manuscript was drafted. SUN is a Mass General Brigham Innovation Fellow with part-time fellowship supported by Sanofi.
